Drug Search Results
More Filters [+]

Sulbactam

Alternative Names: sulbactam, Sulbactam-Durlobactam, SUL-DUR, unasyn
Latest Update: 2024-11-20
Latest Update Note: Clinical Trial Update

Product Description

Sulbactam is in a class of medications called beta-lactamase inhibitors. It works by preventing bacteria from destroying ampicillin. (Sourced from: https://medlineplus.gov/druginfo/meds/a693021.html)

Mechanisms of Action: LACTB Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Brazil | Bulgaria | Chile | China | Colombia | Cyprus | Dominican Republic | Ecuador | Egypt | Estonia | France | Germany | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Japan | Korea | Lithuania | Malaysia | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Spain | Sri Lanka | Taiwan | Thailand | Turkey | Ukraine | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sulbactam

Countries in Clinic: China, Unknown Location

Active Clinical Trial Count: 7

Highest Development Phases

Phase 3: Respiratory Tract Infections|Urinary Tract Infections

Phase 2: Bronchiectasis|Bronchitis, Chronic|Chronic Obstructive Pulmonary Disease|Pneumonia|Pyelonephritis

Phase 1: Arthritis, Infectious|Bacteriuria|Cellulitis|Cystitis|Erysipelas|Gonorrhea|Healthy Volunteers|Lung Abscess|Meningitis, Bacterial|Osteoarthritis|Osteomyelitis|Pelvic Infection|Peritonitis|Pharyngitis|Pneumonia, Bacterial|Sepsis|Sinusitis|Soft Tissue Infections|Tonsillitis|Wound Infection

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2020-001397-30

P3

Active, not recruiting

Unknown

2024-09-03

CTR20132537

P3

Recruiting

Respiratory Tract Infections|Urinary Tract Infections

None

CTR20221980

P1

Active, not recruiting

Healthy Volunteers

None

CTR20130509

P1

Recruiting

Pyelonephritis|Respiratory Tract Infections|Osteoarthritis|Peritonitis|Osteomyelitis|Pneumonia, Bacterial|Erysipelas|Bronchiectasis|Bacteriuria|Cellulitis|Sinusitis|Lung Abscess|Pelvic Infection|Arthritis, Infectious|Bronchitis, Chronic|Pharyngitis|Soft Tissue Infections|Wound Infection|Urinary Tract Infections|Tonsillitis|Cystitis|Gonorrhea|Meningitis, Bacterial|Sepsis

None

Recent News Events